Safety and efficacy of routine postoperative ibuprofen for pain and disability related to ectopic bone formation after hip replacement surgery (HIPAID): randomised controlled trial
- PMID: 16885182
- PMCID: PMC1562471
- DOI: 10.1136/bmj.38925.471146.4F
Safety and efficacy of routine postoperative ibuprofen for pain and disability related to ectopic bone formation after hip replacement surgery (HIPAID): randomised controlled trial
Abstract
Objectives: To determine the benefits and risks of a non-steroidal anti-inflammatory drug (NSAID) as prophylaxis for ectopic bone formation in patients undergoing total hip replacement (or revision) surgery.
Design: Double blind randomised placebo controlled clinical trial, stratified by treatment site and surgery (primary or revision).
Setting: 20 orthopaedic surgery centres in Australia and New Zealand.
Participants: 902 patients undergoing elective primary or revision total hip replacement surgery.
Intervention: 14 days' treatment with ibuprofen (1200 mg daily) or matching placebo started within 24 hours of surgery.
Main outcome measures: Changes in self reported hip pain and physical function 6 to 12 months after surgery (Western Ontario and McMaster University Arthritis index).
Results: There were no significant differences between the groups for improvements in hip pain (mean difference -0.1, 95% confidence interval -0.4 to 0.2, P = 0.6) or physical function (-0.1, -0.4 to 0.2, P = 0.5), despite a decreased risk of ectopic bone formation (relative risk 0.69, 0.56 to 0.83) associated with ibuprofen. There was a significantly increased risk of major bleeding complications in the ibuprofen group during the admission period (2.09, 1.00 to 4.39).
Conclusions: These data do not support the use of routine prophylaxis with NSAIDs in patients undergoing total hip replacement surgery.
Trial registration: NCT00145730.
Figures
Comment in
-
Non-steroidal anti-inflammatory drugs after hip replacement.BMJ. 2006 Sep 9;333(7567):507-8. doi: 10.1136/bmj.38960.600822.80. BMJ. 2006. PMID: 16960187 Free PMC article. No abstract available.
-
Postoperative ibuprofen increased bleeding complications in hospital and did not improve pain or physical function at 6-12 months after total hip replacement.Evid Based Nurs. 2007 Apr;10(2):57. doi: 10.1136/ebn.10.2.57. Evid Based Nurs. 2007. PMID: 17384109 No abstract available.
References
-
- Ethgen O, Bruyere O, Richy F, Dardennes C, Reginster J-Y. Health-related quality of life in total hip and total knee arthroplasty. J Bone Joint Surg 2004;86-A: 963-74. - PubMed
-
- Givon U, Ginsberg GM, Horoszowski H, Shemer J. Cost-utility analysis of total hip arthroplasties. Technology assessment of surgical procedures by mailed questionnaires. Int J Tech Ass Health Care 1998;14: 735-42. - PubMed
-
- Lieberman JR, Dorey F, Shekelle P, Schumacher L, Thomas BJ, Kilgus DJ, et al. Differences between patients' and physicians' evaluations of outcome after total hip arthroplasty. J Bone Joint Surg 1996;78-A(6): 835-8. - PubMed
-
- Williams O, Fitzpatrick R, Hajat S, Reeves BC, Stimpson A, Morris RW, et al. Mortality, morbidity, and 1-year outcomes of primary elective total hip arthroplasty. J Arthroplasty 2002;17: 165-71. - PubMed
-
- Neal B. Effects of heterotopic bone formation on outcome after hip arthroplasty. Aust N Z J Surg 2003;73: 422-6. - PubMed
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical